US adhesives group HB Fuller is acquiring UK-listed surgical adhesives and wound care specialist Advanced Medical Solutions(AMS) in a deal with an enterprise value of £715 million (~ $920 million).
Italian pharmaceutical company Angelini Pharma is acquiring US-based commercial-stage biopharmaceutical company Catalyst Pharmaceuticals for ~$4.1 billion in terms of equity value.
US private equity firm Carlyle has acquired a majority stake in two healthcare revenue cycle management (RCM) platforms: Knack RCM and EqualizeRCM. The investment is being made through Carlyle Asia Partners VI and Carlyle Asia Partners Growth II.
Sun Pharmaceutical, India’s largest drug maker by revenue, has agreed to acquire US-listed Organon, which has a portfolio of therapies and products in women’s health, biosimilars and established medicines, for an enterprise value of $11.7 billion. This marks the largest overseas acquisition by an Indian pharmaceutical company to date.
Kooth is a UK-based digital mental health company that provides free-at-the-point-of-use (publicly reimbursed) support to teenagers and young people in the UK and the US. In a recent conversation with HBI, Kate Newhouse, CEO, explained the company’s ethos and why there is such a need for the kind of early-intervention mental health services it provides.
MGS, a Wisconsin-based healthcare contract development and manufacturing organisation (CDMO), has acquired Knudsen Plast A/S, a Danish company specialising in medical injection moulding with facilities in Denmark and Slovakia.
Sword Health, a US-based AI care company focused on digital treatment for muscle, joint and pelvic health conditions, is acquiring Germany’s Kaia Health in a deal valued at $285 million.
Novo Holdings, the investment arm of Danish enterprise foundation Novo Nordisk Foundation and owner of Danish drug company Novo Nordisk, has bought a 49% stake in India’s Surya Hospitals, the largest chain of women’s and children’s hospitals in western India.
Sun Pharmaceutical Industries, India’s largest drugmaker by market value and revenue, is reportedly looking to acquire US-based Organon, a company focused on women’s health medicines and devices in a deal that could be worth around $10 billion in enterprise value.
If completed, this would be the largest cross-border acquisition by an Indian pharmaceutical company.
UK-based medical technology company Smith+Nephew has agreed to acquire US sports medicine business Integrity Orthopaedics in a deal valued at up to $450 million. The transaction includes an upfront cash payment of $225 million, with an additional $225 million contingent on performance over the next five years.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
